Recently, PR expression has been implicated in breast cancer cell dedifferentiation through miR-141/STAT5a pathway (39) and shorter relapse-free survival in breast cancer (40), suggesting that a dedifferentiation phenotype might contribute to an aggressive behavior of PR-positive tumors, which is agreement with our data. The gene discussed is STAT5A; the disease is breast cancer.